Zhongzhi Pharmaceutical Holdings Limited (3737.HK)

HKD 0.89

(-2.2%)

Revenue Summary of Zhongzhi Pharmaceutical Holdings Limited

  • Zhongzhi Pharmaceutical Holdings Limited's latest annual revenue in 2023 was 2.04 Billion CNY , up 12.26% from previous year.
  • Zhongzhi Pharmaceutical Holdings Limited's latest quarterly revenue in 2024 Q2 was 1.08 Billion CNY , up 13.91% from previous quarter.
  • Zhongzhi Pharmaceutical Holdings Limited reported a annual revenue of 1.82 Billion CNY in annual revenue 2022, up 4.55% from previous year.
  • Zhongzhi Pharmaceutical Holdings Limited reported a annual revenue of 1.74 Billion CNY in annual revenue 2021, up 8.89% from previous year.
  • Zhongzhi Pharmaceutical Holdings Limited reported a quarterly revenue of 1.09 Billion CNY for 2023 Q2, up 11.72% from previous quarter.
  • Zhongzhi Pharmaceutical Holdings Limited reported a quarterly revenue of 2.04 Billion CNY for 2023 FY, up 12.26% from previous quarter.

Annual Revenue Chart of Zhongzhi Pharmaceutical Holdings Limited (2023 - 2013)

Historical Annual Revenue of Zhongzhi Pharmaceutical Holdings Limited (2023 - 2013)

Year Revenue Revenue Growth
2023 2.04 Billion CNY 12.26%
2022 1.82 Billion CNY 4.55%
2021 1.74 Billion CNY 8.89%
2020 1.6 Billion CNY 19.5%
2019 1.34 Billion CNY 17.51%
2018 1.14 Billion CNY 20.91%
2017 944.63 Million CNY 29.32%
2016 730.47 Million CNY 6.17%
2015 688.03 Million CNY 15.53%
2014 595.56 Million CNY 23.36%
2013 482.8 Million CNY 0.0%

Peer Revenue Comparison of Zhongzhi Pharmaceutical Holdings Limited

Name Revenue Revenue Difference
Pak Fah Yeow International Limited 259.15 Million HKD -690.951%
Grand Pharmaceutical Group Limited 10.52 Billion HKD 80.533%
Extrawell Pharmaceutical Holdings Limited 59.09 Million HKD -3368.496%
Wai Yuen Tong Medicine Holdings Limited 783.88 Million HKD -161.495%
Qianhai Health Holdings Limited 961.29 Million HKD -113.235%
Lee's Pharmaceutical Holdings Limited 1.05 Billion HKD -94.658%
Essex Bio-Technology Limited 1.7 Billion HKD -20.114%
Tongfang Kontafarma Holdings Limited 809.1 Million HKD -153.343%
PuraPharm Corporation Limited 406.85 Million HKD -403.814%
SSY Group Limited 6.46 Billion HKD 68.284%
JBM (Healthcare) Limited 648.41 Million HKD -216.127%
Jacobson Pharma Corporation Limited 1.46 Billion HKD -39.652%
China Resources Pharmaceutical Group Limited 270.39 Billion HKD 99.242%